The DOI matches its Crossref record; 134 of the 136 references it cites were found in a registry or an index.
Tumor-Associated Macrophages: From Mechanisms to Therapy
Open accessAbstract
The tumor microenvironment is a complex ecology of cells that evolves with and provides support to tumor cells during the transition to malignancy. Among the innate and adaptive immune cells recruited to the tumor site, macrophages are particularly abundant and are present at all stages of tumor progression. Clinical studies and experimental mouse models indicate that these macrophages generally play a protumoral role. In the primary tumor, macrophages can stimulate angiogenesis and enhance tumor cell invasion, motility, and intravasation. During monocytes and/or metastasis, macrophages prime the premetastatic site and promote tumor cell extravasation, survival, and persistent growth. Macrophages are also immunosuppressive, preventing tumor cell attack by natural killer and T cells during tumor progression and after recovery from chemo- or immunotherapy. Therapeutic success in targeting these protumoral roles in preclinical models and in early clinical trials suggests that macrophages are attractive targets as part of combination therapy in cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, TAM-based therapeutic strategies are being developed that aim at TAM targeting, TAM re-education, and TAM depletion [88, 96, 101, 102].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [88]
The cited source says what the claim attributes to it.
In the citing paper
“Many therapy strategies have attempted to alter the polarization of macrophages’ “re-programming” or prevent monocyte tumor infiltration (Noy and Pollard, 2014).”
From Sysrev: A FAIR Platform for Data Curation and Systematic Evidence Review (2021) · cites this paper as Noy and Pollard, 2014
In the citing paper
“In preclinical models, both of these innate immune cell types aid tumor growth and metastasis through their secretion of factors that suppress antitumor immune responses, especially those of CD8 + T cells and NK cells (166, 167).”
From Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance (2021) · cites this paper as [167]
In the citing paper
“The production of colony stimulating factor 1 (CSF-1; also known as macrophage colony stimulating factor) by BCCs, has been reported to stimulate the recruitment of macrophages to primary breast tumors, leading to the secretion by tumor-associated macrophages (TAMs) of epidermal growth factor, which binds to its cognate receptor on BCCs to stimulate invasion and metastasis [36–38].”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Forget, M. A., Voorhees, J. L., Cole, S. L., Dakhlallah, D. A., Patterson, I. L., Gross, A. C., Moldovan, L., Mo, X. M., Evans, R., Marsh, C. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098623 · Cited by 79 · cited 2×
“Interestingly, CSF1 upregulates TIE2 on TAMs (Forget et al., 2014) indicating a link between CSF1, TIE2 macrophages, and the induction of the angiogenic switch.”
BackgroundRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“…the ways in which the microenvironmental support to tumors is the acquisition of a vasculature that provides oxygenation, as well as the nutrition and waste disposal required for growth above a certain size in a process often referred to as the ‘‘angiogenic switch’’ (Hanahan and Weinberg, 2011).”
BackgroundCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · cited 1×
“Furthermore, inflammatory conditions such as Crohn’s disease dramatically increase the risk of colorectal cancer (Balkwill et al., 2005; Balkwill and Mantovani, 2012; Coussens and Werb, 2002; Grivennikov et al., 2010).”
BackgroundImmunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · cited 4×
“Furthermore, inflammatory conditions such as Crohn’s disease dramatically increase the risk of colorectal cancer (Balkwill et al., 2005; Balkwill and Mantovani, 2012; Coussens and Werb, 2002; Grivennikov et al., 2010).”
BackgroundInfluentialMicroenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · cited 3×
“…SPARC) that increases tumor cell-ECM interaction and thus migration (Sangaletti et al., 2008), Cathepsin proteases that remodel the matrix and release sequestered growth factors (Laoui et al., 2011; Quail and Joyce, 2013) and TGF-b that promotes EMT of the invading tumor cells (Bonde et al., 2012).”
BackgroundMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 1×
“TheseM-MDSCs have greater immunosuppressive potency than the granulocytic ones and are further defined as F4/80+ a marker also found on inflammatory monocytes (Gabrilovich and Nagaraj, 2009; Gabrilovich et al., 2012).”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 2×
“References to these polarizing agents can be found in (De Palma and Lewis, 2013; Sica and Mantovani, 2012). above strongly support targeting the destruction or redifferentiation of macrophages as an important part of combinatorial therapies in human cancer patients.”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189 · cited 1×
“…the activated macrophages responding to IFN-g, TNF-a, and Toll-like receptor 4 (TLR4) activation capable of killing pathogens through mechanisms such as iNOS, and (2) alternatively activated macrophages responding to IL-4 and IL-13 involved in antiparasitic immunity and in asthma (Gordon, 2003).”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,349 · cited 11×
“Furthermore, in most large-scale transcriptome analysis, macrophages have a mixed phenotype expressing both M1 and M2 markers (Qian and Pollard, 2010).”
BackgroundInfluentialSelf-citation
Flagged first, then by citations
2 of the 136 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,010
Qu, X., Zhou, D. F., Lu, J., Qin, D., Zhou, J. M., & Liu, H.-J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.12.010 · Cited by 78
CD8+ T cell exhaustion in the tumor microenvironment of breast cancer
Xie, H., Xi, X., Lei, T., Liu, H., & Xia, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1507283 · Cited by 79
Lohse, S., Meyer, S., Meulenbroek, L. A. P. M., Jansen, J. H. M., Nederend, M., Kretschmer, A., Klausz, K., Möginger, U., Derer, S., Rösner, T., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1232 · Cited by 81
Sakakura, K., Takahashi, H., Kaira, K., Toyoda, M., Murata, T., Ohnishi, H., Oyama, T., & Chikamatsu, K. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.70 · Cited by 77
Petruzzi, M. N. M. R., Cherubini, K., Salum, F. G., & de Figueiredo, M. A. Z. (2017) · Diagnostic Pathology · doi:10.1186/s13000-017-0623-6 · Cited by 78
Macrophages play an essential role in trauma-induced sterile inflammation and tissue repair
Peiseler, M., & Kubes, P. (2018) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-018-0956-1 · Cited by 79
Rassy, E., Botticella, A., Kattan, J. G., Pechoux, C. L., Besse, B., & Hendriks, L. E. L. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.05.015 · Cited by 77
The NG2 Proteoglycan in Pericyte Biology
Stallcup, W. B. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-02601-1_2 · Cited by 75
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth
Mathivet, T., Bouleti, C., Woensel, M. V., Stanchi, F., Verschuere, T., Phng, L., Dejaegher, J., Balcer, M., Matsumoto, K., Georgieva, P. B., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607445 · Cited by 76
Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma
Wang, Z., Wang, Z., Li, B., Wang, S., Chen, T., & Ye, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01114 · Cited by 77
Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies
Petty, A. J., & Yang, Y. (2019) · Cells · doi:10.3390/cells8121526 · Cited by 77
LYVE1+ macrophages of murine peritoneal mesothelium promote omentum-independent ovarian tumor growth
Zhang, N., Kim, S. H., Gainullina, A., Erlich, E. C., Onufer, E. J., Kim, J., Czepielewski, R. S., Helmink, B. A., Dominguez, J. R., Saunders, B. T., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210924 · Cited by 75
The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies
Hassani, B., Attar, Z., & Firouzabadi, N. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03080-9 · Cited by 83
“These intratumoral immune cells contribute to the formation of immunosuppressive microenvironment [223, 224].”
BackgroundMacrophages at the Fork in the Road to Health or Disease
Mills, C. D., Lenz, L. L., & Ley, K. F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00059 · Cited by 76
The re-polarisation of M2 and M1 macrophages and its role on cancer outcomes
den Breems, N. Y., & Eftimie, R. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.10.034 · Cited by 80
Liang, P., Henning, S. M., Schokrpur, S., Wu, L., Doan, N., SAID, J. W., Grogan, T., Elashoff, D. A., Cohen, P., & Aronson, W. J. (2016) · The Prostate · doi:10.1002/pros.23218 · Cited by 76
mTOR co-targeting strategies for head and neck cancer therapy
Wang, Z., Valera, J. L. C., Zhao, X., Chen, Q., & Gutkind, J. S. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9688-7 · Cited by 79
Liu, T., Larionova, I., Литвяков, Н. В., Riabov, V., Zavyalova, M. V., Tsyganov, M. M., Buldakov, M. A., Song, B., Moganti, K., Вадимовна, К. П., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1436922 · Cited by 76
Vahidian, F., Duijf, P. H. G., Safarzadeh, E., Derakhshani, A., Baghbanzadeh, A., & Baradaran, B. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.03.004 · Cited by 75
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Wang, Y., Mohseni, M., Grauel, A., Diez, J. E., Guan, W., Liang, S., Choi, J. E., Pu, M., Chen, D., Laszewski, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-80999-x · Cited by 73
Emerging approaches to study cell-cell interactions in tumor microenvironment
Nishida‐Aoki, N., & Gujral, T. S. (2019) · Oncotarget · doi:10.18632/oncotarget.26585 · Cited by 76
Tumor Cells Induce LAMP2a Expression in Tumor-Associated Macrophage for Cancer Progression
Wang, R., Liu, Y., Liu, L., Chen, M., Wang, X., Yang, H. J., Gong, Y., Ding, B., Wei, Y., & Wei, X. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.045 · Cited by 76
Immune gene expression profiling reveals heterogeneity in luminal breast tumors
Zhu, B., Tse, L. A., Wang, D., Koka, H., Zhang, T., Abubakar, M., Lee, P. M. Y., Wang, F., Wu, Ç., Tsang, K. H., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1218-9 · Cited by 75
Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity
Papadas, A., Arauz, G., Cicala, A., Wiesner, J., & Asimakopoulos, F. A. (2020) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155420937098 · Cited by 75
Gómez, V., Eykyn, T. R., Mustapha, R., Flores‐Borja, F., Male, V. H., Barber, P. R., Patsialou, A., Green, R. J., Panagaki, F., Li, C. W., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aax4585 · Cited by 77
Wei, R., Zhu, W., Yu, G., Wang, X., Gao, C., Xu, Z., Lin, Z., Shao, W., Wang, S., Lü, M., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33371 · Cited by 75
Tao, H., Liu, M., Wang, Y., Luo, S., Xu, Y., Ye, B., Zheng, L., Meng, K., & Li, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.609295 · Cited by 75
Zhou, M., Wang, C., Lu, S., Xu, Y., Li, Z., Jiang, H., & Ma, Y. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103375 · Cited by 75
Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib
Ran, F., Liu, Y., Wang, C., Xu, Z., Zhang, Y., Liu, Y., Zhao, G., & Ling, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114009 · Cited by 76
Liu, Q., Zhao, E., Geng, B., Gao, S., Yu, H., He, X., Li, X., Dong, G., & You, B. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04814-9 · Cited by 75
Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway
Cheng, L., Zhang, P., Liu, Y., Liu, Z., Tang, J., Xu, L., & Liu, J. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122259 · Cited by 79
Zhao, Y., Wang, D., Xu, T., Liu, P., Cao, Y., Wang, Y., Yang, X., Xu, X., Wang, X., & Niu, H. (2015) · Oncotarget · doi:10.18632/oncotarget.5538 · Cited by 74
Kim, D., Dastidar, H., Zhang, C., Zemp, F. J., Lau, K. C. K., Ernst, M., Rakic, A., Sikdar, S., Rajwani, J., Naumenko, V., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00324-x · Cited by 80
Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions
Roy, S., Bag, A. K., Dutta, S., Polavaram, N. S., Islam, R., Schellenburg, S., Banwait, J., Guda, C., Ran, S., Hollingsworth, M. A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0562 · Cited by 80
Macrophages Support Splenic Erythropoiesis in 4T1 Tumor-Bearing Mice
Liu, M., Jin, X., He, X., Pan, L., Zhang, X., & Zhao, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121921 · Cited by 72
Jiang, Z., Zhang, Y., Zhang, Y., Jia, Z., Zhang, Z., & Yang, J. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00768-1 · Cited by 77
Leblond, M. M., Zdimerova, H., Desponds, E., & Verdeil, G. (2021) · Cancers · doi:10.3390/cancers13184712 · Cited by 75
Wei, Y., Wang, Z., Yang, J., Xu, R. F., Deng, H., Ma, S., Fang, T., Zhang, J., & Shen, Q. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.09.160 · Cited by 77
Targeting Tumor-Associated Macrophages in Cancer Immunotherapy
Petty, A. J., Owen, D. H., Yang, Y., & Huang, X. (2021) · Cancers · doi:10.3390/cancers13215318 · Cited by 79
Shi, B., Chu, J., Huang, T., Wang, X., Li, Q., Gao, Q., Xia, Q., & Luo, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.771488 · Cited by 74
Chen, M., Xiao, C., Lao, X., Yuan, W., Liu, R., Zeng, Q., Wang, J., Ouyang, F., Chen, D., Chan, K., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0329 · Cited by 74
One microenvironment does not fit all: heterogeneity beyond cancer cells
Kim, I. S., & Zhang, X. H.-F. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9643-z · Cited by 75
Lipid-loaded macrophages as new therapeutic target in cancer
Marelli, G., Morina, N., Portale, F., Pandini, M., Iovino, M., Di Conza, G., Ho, P.-C., & Di Mitri, D. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004584 · Cited by 69
LncRNA HOTAIR in Tumor Microenvironment: What Role?
Botti, G., Scognamiglio, G., Aquino, G., Liguori, G., & Cantile, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092279 · Cited by 72
Bi, S., Huang, W., Chen, S., Huang, C., Li, C., Guo, Z., Yang, J., Zhu, J., Song, L., & Yu, R. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.050 · Cited by 76
Lu, J., Xu, Z., Duan, H., Ji, H., Zhen, Z., Li, B., Wang, H., Tang, H., Zhou, J., Guo, T., et al. (2020) · Cancer Science · doi:10.1111/cas.14408 · Cited by 74
“Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma
Liu, K. X., & Joshi, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01947 · Cited by 74
Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
Zhou, D., Luan, J., Huang, C., & Li, J. (2020) · Gut and Liver · doi:10.5009/gnl20223 · Cited by 74
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
Qin, Y., Zheng, X., Gao, W., Wang, B., & Wu, Y. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.01.011 · Cited by 76
The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy
Li, Z., Li, Y., Gao, J., Fu, Y., Hua, P., Jing, Y., Cai, M., Wang, H., & Tong, T. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119150 · Cited by 76
Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
Pagano, E., Elias, J. E., Schneditz, G., Saveljeva, S., Holland, L. M., Borrelli, F., Karlsen, T. H., Kaser, A., & Kaneider, N. C. (2021) · Gut · doi:10.1136/gutjnl-2020-323363 · Cited by 76
AIF1: Function and Connection with Inflammatory Diseases
León-Oliva, D. D., Montero, C. G., Fraile‐Μartinez, O., Boaru, D. L., García-Puente, L., Rios‐Parra, A., Garrido-Gil, M. J., Casanova-Martín, C., García‐Honduvilla, N., Buján, J., et al. (2023) · Biology · doi:10.3390/biology12050694 · Cited by 78
Luo, F., Li, H., Ma, W., Cao, J., Chen, Q., Lu, F., Qiu, M., Zhou, P., Xia, Z., Zeng, K., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01112-y · Cited by 77
Dwyer, A. R., Greenland, E. L., & Pixley, F. J. (2017) · Cancers · doi:10.3390/cancers9060068 · Cited by 75
Ishikane, S., & Takahashi‐Yanaga, F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.008 · Cited by 73
Li, X., Jolly, M. K., George, J. T., Pienta, K. J., & Levine, H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00010 · Cited by 73
An immune infiltration signature to predict the overall survival of patients with colon cancer
Peng, D., Wang, L., Li, H., Cai, C., Tan, Y. S., Xu, B., & Le, H. (2019) · IUBMB Life · doi:10.1002/iub.2124 · Cited by 72
Cao, W., Liu, B., Xia, F., Duan, M., Hong, Y., Niu, J., Wang, L., Liu, Y., Li, C., & Cui, D. (2019) · Nanoscale · doi:10.1039/c9nr07947e · Cited by 73
Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer
Song, X., Traub, B., Shi, J., & Kornmann, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020727 · Cited by 72
Yin, W., Li, Y., Song, Y. Y., Zhang, J., Wu, C., Chen, Y., Miao, Y., Lin, C., Lin, Y., Yan, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024171118 · Cited by 70
Hasan, M. N., Capuk, O., Patel, S. M., & Sun, D. (2022) · Cancers · doi:10.3390/cancers14143331 · Cited by 75
Boelaars, K., Rodríguez, E., Huinen, Z. R., Liu, C., Wang, D., Springer, B. O., Olesek, K., Kruijssen, L. J. W., van Ee, T., Lindijer, D., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06087-8 · Cited by 75
“In cancer, Siglec-7, -9, -10 and -15 play a key role in facilitating immune evasion 36 – 41 .”
BackgroundInfluentialSun, Z.-Q., Xu, Y.-X., Shao, B., Dang, P., Hu, S.-Y., Sun, H., Chen, C., Wang, C., Liu, J.-B., Liu, Y., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008491 · Cited by 75
Molecular Imaging of Tumor-Infiltrating Macrophages in a Preclinical Mouse Model of Breast Cancer
Sun, X., Gao, D., Gao, L., Zhang, C., Yu, X., Jia, B., Wang, F., & Liu, Z. (2015) · Theranostics · doi:10.7150/thno.11546 · Cited by 74
Soldano, S., Pizzorni, C., Paolino, S., Trombetta, A. C., Montagna, P., Brizzolara, R., Ruaro, B., Sulli, A., & Cutolo, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166433 · Cited by 75
Relation, T., Yi, T., Guess, A. J., Perle, K. L., Otsuru, S., Hasgur, S., Dominici, M., Breuer, C. K., & Horwitz, E. M. (2018) · Stem Cells · doi:10.1002/stem.2801 · Cited by 72
Fokas, E., O’Neill, E., Gordon-Weeks, A. N., Mukherjee, S., McKenna, W. G., & Muschel, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.12.001 · Cited by 75
Tsukamoto, M., Imai, K., Ishimoto, T., Komohara, Y., Yamashita, Y., Nakagawa, S., Umezaki, N., Yamao, T., Kitano, Y., Miyata, T., et al. (2018) · Cancer Science · doi:10.1111/cas.13874 · Cited by 75
Autio, K. A., Klebanoff, C. A., Schaer, D., Kauh, J. S. W., Slovin, S. F., Adamow, M. J., Blinder, V. S., Brahmachary, M., Carlsen, M., Comen, E. A., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0855 · Cited by 72
Beatson, R., Graham, R. A., Freile, F. G., Cozzetto, D., Kannambath, S., Pfeifer, E., Woodman, N. L., Owen, J., Nuamah, R. A., Mandel, U., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01359-5 · Cited by 71
The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities
Lin, J., Ren, J., Gao, D. S., Dai, Y., & Yu, L. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.669308 · Cited by 71
Cancer-fighting potentials of algal polysaccharides as nutraceuticals
Ouyang, Y., Qiu, Y., Liu, Y., Zhu, R., Chen, Y., El-Seedi, H. R., Chen, X., & Zhao, C. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110522 · Cited by 71
Cao, Y., Qiao, B., Chen, Q., Xie, Z., Dou, X., Xu, L., Ran, H., Zhang, L., & Wang, Z. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.02.006 · Cited by 74
HOXB7 Promotes Malignant Progression by Activating the TGFβ Signaling Pathway
Liu, S., Jin, K., Hui, Y. Y., Fu, J., Jie, C., Feng, S., Reisman, D., Wang, Q., Fan, D., Sukumar, S. V., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-3100 · Cited by 71
Wang, H., Shao, Q., Sun, J., Ma, C., Gao, W., Wang, Q., Zhao, L., & Qu, X. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1122157 · Cited by 74
Wu, Q., Allouch, A., Martins, I., Brenner, C., Modjtahedi, N., Deutsch, É., & Perfettini, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00613 · Cited by 76
Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages
Kwon, Y., Kim, M.-S., Kim, Y., Jung, H. S., & Jeoung, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01167 · Cited by 75
Wu, H., Zhang, X., Han, D., Cao, J., & Tian, J. (2020) · PeerJ · doi:10.7717/peerj.8721 · Cited by 69
Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression
Bi, Y., Shirure, V. S., Liu, R., Cunningham, C., Ding, L., Meacham, J. M., Goedegebuure, S. P., George, S. C., & Fields, R. C. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa017 · Cited by 75
Rabold, K., Aschenbrenner, A. C., Thiele, C., Boahen, C. K., Schiltmans, A., Smit, J. W. A., Schultze, J. L., Netea, M. G., Adema, G. J., & Netea-Maier, R. T. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000638 · Cited by 73
Schenkel, L. B., Molina, J. R., Swinger, K. K., Abo, R., Blackwell, D. J., Lu, A. Z., Cheung, A. E., Church, W. D., Kunii, K., Kuplast-Barr, K. G., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.02.010 · Cited by 71
Brown, M. C., Mosaheb, M., Mohme, M., McKay, Z. P., Holl, E. K., Kastan, J. P., Yang, Y., Beasley, G. M., Hwang, E., Ashley, D. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22088-1 · Cited by 70
Cotechini, T., Atallah, A., & Grossman, A. (2021) · Cells · doi:10.3390/cells10040960 · Cited by 74
Roles of tumor-associated neutrophils in tumor metastasis and its clinical applications
Yan, M., Zheng, M., Niu, R., Yang, X., Tian, S., Fan, L., Li, Y., & Zhang, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.938289 · Cited by 72
Wang, H., Haung, L.-Y., Wang, C., Chao, Y., Hou, Y., Yen, C., & Shan, Y. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00881-4 · Cited by 70
Gao, L., Shi, C., Yang, Z., Jing, W., Han, M., Zhang, J., Zhang, C., Tang, C., Dong, Y., Liu, Y., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01810-9 · Cited by 79
Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy
Zeng, Q., Liu, M., Wang, Z., Zhou, R., & Ai, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02366-y · Cited by 90
“M1 and M2 macrophages represent two extremes on a functional continuum of fully polarized anti-tumor TAMs and immunosuppressive TAMs, respectively [161].”
Emerging therapeutic targets in metastatic progression: A focus on breast cancer
Li, Z., & Kang, Y. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.003 · Cited by 71
Optimizing T-cell receptor gene therapy for hematologic malignancies
Morris, E. C., & Stauss, H. J. (2016) · Blood · doi:10.1182/blood-2015-11-629071 · Cited by 72
Mao, L., Zhao, Z., Yu, G., Wu, L., Deng, W., Li, Y., Liu, J., Bu, L., Liu, B., Kulkarni, A. B., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31115 · Cited by 70
Monocyte-mediated Chemotherapy Drug Delivery in Glioblastoma
Wang, C., Li, K., Li, T., Chen, Z., Wen, Y., Liu, X., Jia, X., Zhang, Y., Xu, Y., Han, M. H., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0266 · Cited by 73
Porta, C., Sica, A., & Riboldi, E. (2017) · FEBS Journal · doi:10.1111/febs.14288 · Cited by 70
Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
Liu, Y., Wang, X., & Yang, Y. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0178 · Cited by 75
Macrophages in pancreatic cancer: An immunometabolic perspective
Yang, J. M., Li, Y., Sun, Z., & Zhan, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.029 · Cited by 72
López-Codony, V., & Tavassoli, M. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101017 · Cited by 73
Müller, A., Köhler, U. A., Trzebanski, S., Vinik, Y., Raj, H., Girault, J., Ben‐Chetrit, N., Maraver, A., Jung, S., & Lev, S. (2022) · Advanced Science · doi:10.1002/advs.202105696 · Cited by 69
Xiao, J., Sun, F., Wang, Y., Лю, Б., Zhou, P., Wang, F., Zhou, H., Ge, Y., Yue, T., Luo, J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci158352 · Cited by 69
Yang, F., Zhang, D., Jiang, H., Ye, J., Zhang, L., Bagley, S. J., Winkler, J. D., Gong, Y., & Fan, Y. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq3558 · Cited by 70
Ye, X., Huang, X., Fu, X., Zhang, X., Lin, R., Zhang, W., Zhang, J., & Lü, Y. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01442-4 · Cited by 69
The covariance environment defines cellular niches for spatial inference
Haviv, D., Remšík, J., Gatie, M. I., Snopkowski, C., Takizawa, M., Pereira, N., Bashkin, J., Jovanovich, S. B., Nawy, T., Chaligné, R., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02193-4 · Cited by 72
Metadata
- Authors
- Noy, R., & Pollard, J. W.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Pollard, Jeffrey W.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 41
- Issue
- 1
- Pages
- 49-61
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC4137410
- OpenAlex
- W1971620413
- Cited by
- 4,089
- References
- 136
- Citations by year
- 2026: 258 · 2025: 326 · 2024: 359 · 2023: 393 · 2022: 485 · 2021: 479 · 2020: 424 · 2019: 379 · 2018: 297 · 2017: 285 · 2016: 215 · 2015: 157 · 2014: 27
- FWCI
- 22.25
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-11-20)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust (101067, 101067/Z/13/Z)
- National Institutes of Health (UL1TR001073)
- National Cancer Institute (P01CA100324, R01CA172451)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor-associated macrophages, tumor microenvironment, tumor angiogenesis, tumor invasion, metastasis, pre-metastatic niche, immunosuppression, natural killer cells, T cells, macrophage-targeted therapy, combination cancer therapy
- MeSH terms
- Animals, Cell Movement, Cell Survival, Cell Transformation, Neoplastic, Humans, Immunosuppression Therapy, Macrophages, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Cell Lineage, Cell Proliferation, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
